<DOC>
	<DOCNO>NCT01197482</DOCNO>
	<brief_summary>Investigational device : AKITA 2 device versus conventional metered-dose inhaler ( MDI ) Objectives : To explore inhalative fluticasone application mean AKITA technology would result good symptom control patient severe persistent asthma compare inhalative application fluticasone conventional MDI . Study design : open label , cross-over ( one AKITA , one MDI arm ) Patients : 20 Patients severe persistent asthma</brief_summary>
	<brief_title>Inhaled Steroids Control Severe Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Severe persistent asthma bronchiale diagnosis accord criterion Global Initiative Asthma ( GINA ) executive summary Treatment least inhaled corticosteroid ( ICS ) long act b agonist ( LABA ) Evidence inflammatory trigger form asthma least one following : sensitization typical aerogenous allergen increase Serum IgE level Eosinophilia peripheral blood Proven Eosinophilia sputum differential ( &gt; 3 % ) previous 2 year least 2 exacerbation asthma within previous 24 month lead unscheduled presentation health care provider and/or systemic corticosteroid Signed informed consent Requirements local ethic committee meet Acute exacerbation asthma within last 6 week Rtot &gt; 350 % predict capillary pO2 &lt; 60mmHG , pCo2 &gt; 50mmHG near fatal asthma anaphylaxis history Age â‰¤ 18 &gt; 80 year Active smoking &gt; 15 packyears former smoke Oral steroid treatment prednisolonequivalent dose exceed 10 mg per day Pregnancy , nursing female Female without use effective contraceptive method Treatment investigational drug past 30 day course trial Severe uncontrolled gastroesophageal reflux disease Ongoing psychiatric disorder Treatment systemic corticosteroid reason asthma Other active lung diseases Medical history uncontrolled diseases 3 month prior randomization ( e.g . infection , coronary heart diseases metabolic disease ) Any history malignancy require ongoing treatment and/or limit lifeexpectancy Clinically significant abnormality electrocardiogram ( ECG ) laboratory exam Asthma relate nonsteroidal antiinflammatory drug ( NSAID ) Insulin dependent diabetes mellitus Cataract</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>asthma</keyword>
	<keyword>inhalation</keyword>
</DOC>